CASP3 and Stroke: Similarly, endogenous NPCs that migrate to the injury site following stroke have been shown to undergo caspase-3-mediated cell death and, importantly, NPC cell death can be prevented using a pan-caspase inhibitor such as zVAD-fmk [44].